http://www.oncternal.com
Oncternal Therapeutics, Inc. Company Intro
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Industry
Healthcare
Oncternal Therapeutics, Inc. Headquaters
12230 El Camino Real
San Diego,92130
United States
Oncternal Therapeutics, Inc. Share price
17 May 2023 13:40 GMT
$0.3000
0.01 (3.31 %)
Oncternal Therapeutics, Inc. Market cap
$17.026 M
WMC RANKING
2023
Oncternal Therapeutics, Inc. # 239
BiotechnologyLatest Oncternal Therapeutics, Inc. News
02 Oct 2023
Prostate Cancer Pipeline Drugs Analysis Report (2023 ...
... Therapeutics, Inc. reported full data from its Phase IIa trial of BXCL701 ... Oncternal Therapeutics, Immunic AG, BioNTech SE, and others. Prostate Cancer...
02 Oct 2023
Prostate Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies ...
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prostate Cancer pipeline constitutes 200+ key companies continuously working...
02 Oct 2023
Prostate Cancer Pipeline Drugs Analysis Report (2023 ...
... Therapeutics, Inc. reported full data from its Phase IIa trial of BXCL701 ... Oncternal Therapeutics, Immunic AG, BioNTech SE, and others. Prostate Cancer...
WMC Market Score
WMC Market to Revenue Score
Oncternal Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Oncternal Therapeutics, Inc. | USD | $3,545 | $22,295 | $-18,435 | $170M | 239 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Oncternal Therapeutics, Inc. | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
